DENTSPLY SIRONA Inc (XRAY) Stock Analysis
Verdict: HOLD
Persistent dental equipment weakness and $2.31B debt weigh on earnings, while deep valuation (P/S 0.52x) and insider buying limit downside.
Investment score: 49/100
Analysis as of
Is DENTSPLY SIRONA Inc stock worth reviewing? AI model thesis
The AI model advises HOLD for XRAY. Deep valuation (P/S 0.52x) and insider buys offset structural margin pressure and debt leverage.
7-factor investment score
- Valuation: 58/100 (weight 20%)
- Financial Health: 35/100 (weight 15%)
- Technical Momentum: 25/100 (weight 15%)
- Earnings Quality: 45/100 (weight 15%)
- Insider Sentiment: 85/100 (weight 10%)
- Analyst Consensus: 60/100 (weight 10%)
- Risk-Adjusted Return: 45/100 (weight 15%)
DENTSPLY SIRONA Inc opportunities and risks
What speaks for XRAY
- Deep Valuation Discount vs Healthcare Peers
What speaks against XRAY
- High Debt Burden and Interest Coverage Risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| XRAY | n/a | 0.5x | 23.1x | 49.5% | -15.0% | 7.5% |
| MMSI | 35.8x | 3.3x | 15.5x | 49.5% | 9.2% | 3.9% |
| HAE | 51.7x | 3.6x | 22.2x | 57.4% | 7.1% | 6.0% |
| ICUI | 138.7x | 1.9x | 17.2x | 37.6% | 1.4% | 3.7% |
| QDEL | n/a | 0.3x | n/a | 44.6% | -39.2% | -28.7% |
| NEOG | n/a | 3.4x | 20.7x | 46.9% | -0.9% | 1.1% |
| Peer median | 35.8x | 3.3x | 17.2x | 46.9% | 1.4% | 3.7% |
Frequently asked questions about DENTSPLY SIRONA Inc (XRAY)
Is XRAY stock a good investment?
The cached TradeMates AI model rates DENTSPLY SIRONA Inc as HOLD with an investment score of 49/100. The AI model advises HOLD for XRAY. Deep valuation (P/S 0.52x) and insider buys offset structural margin pressure and debt leverage. This is algorithmic model output, not personal investment advice.
Is XRAY stock a buy?
The TradeMates model verdict for XRAY is HOLD with an investment score of 49/100. Treat this as a model signal to review, not a personal buy recommendation.